The acronyms USP, IP, BP, JP, and EP are more than mere technical markers; they are seals of scientific integrity. These pharmacopoeias provide the rigorous analytical frameworks that ensure every Active Pharmaceutical Ingredient (API) and finished dosage form possesses the identity, purity, and potency required to deliver its intended therapeutic outcome safely and predictably. For the modern pharmaceutical executive, mastery of these standards is a core component of market

From tariff shocks to “Buy American” pressures, Trump’s policies tested Indian pharma’s resilience. Yet, in the world’s largest drug...